2 May 2018

On Thursday 26 April, nine employees of Radboud University and Radboud university medical center received royal honours for their outstanding scientific or social merit.

Baziel van Engelen conducts research on neuromuscular disorders. He is one of the most prominent neurologists in the Netherlands, sits on various scientific advisory councils and evaluation committees and is a valued member of various professional and scientific organizations. He was Director of Science at the European Neuromuscular Center (ENMC), which brings together researchers of many rare muscle diseases worldwide, share results and jointly develops therapies for these disorders.organizations. As a philosopher and ethicist, Baziel van Engelen has a broad perspective on healthcare with the mission to preserve its human element and foster solidarity in an environment subject to strong commercialization over the years. With great enthusiasm and with a small team of colleagues, he developed innovative ethics training programs for co-assistants, transforming them into doctors who take a human approach.commercializationover the years. With great enthusiasm and with a small team of colleagues, he developed innovative ethics training programs for co-assistants, transforming them into doctors who take a human approach.

Read more Royal honours for nine Radboudians
 

Related news items


Social media posts on medication use during pregnancy often incorrect

23 August 2019

Dutch social media regularly post about the safety of medicines for pregnant women. Many pregnant women use these posts as a source of information. A new analysis shows, however, that information found on social media about the risk of medication use often does not correspond with guidelines.

read more

Hans van Bokhoven newly elected in Academia Europaea

22 August 2019

The Academia Europaea is a functioning European Academy of Humanities, Letters and Sciences, composed of individual members.

read more

Drug-induced interstitial lung disease in advanced breast cancer patients receiving everolimus

22 August 2019

In Targeted Oncology, Annelieke Willemsen, Carla van Herpen and colleagues, showed that pulmonary function test with diffusion capacity of the lungs for carbon monoxide and serum biomarkers can be of aid to differentiate everolimus-related interstitial lung disease from other respiratory problems.

read more

Publication in PNAS on dissecting EEC syndrome using single-cell RNA-seq

22 August 2019

PhD candidates Eduardo Soares and Quan Xu in Jo Huiqing Zhou’s group in Molecular Developmental Biology, theme Reconstruction and regenerative medicine, have published a paper in PNAS on the disease mechanism of EEC syndrome using single-cell RNA-seq technology and patient-derived iPSCs.

read more

Patient trust and participation in cell biological research

21 August 2019

Alessandra Cambi and Gert Olthuis, discuss key ethical issues inherent in the development and the value of building trust and trustworthiness.

read more

NWO grant for a tissue-generating patch to close diaphragmatic defects

21 August 2019

Willeke Daamen and Toin van Kuppevelt, theme Reconstructive and regenerative medicine, were recently awarded a 690 k€ grant by NWO, domain Applied & Engineering Sciences, for the development of advanced patches for closure of diaphragmatic defects in children with congenital diaphragmatic hernia.

read more